Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-25-055326
Filing Date
2025-06-02
Accepted
2025-06-02 12:12:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 15789
2 EXHIBIT A tm2516827d1_exa.htm EX-99.A 6211
  Complete submission text file 0001104659-25-055326.txt   23803
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Subject) CIK: 0001845459 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-92576 | Film No.: 251013804
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1120 N. TOWN CENTER DRIVE SUITE 150 LAS VEGAS NV 89144
Business Address 1120 N. TOWN CENTER DRIVE SUITE 150 LAS VEGAS NV 89144 626-799-9898
CFIC-2015 NV Family Investments, LLC (Filed by) CIK: 0002034776 (see all company filings)

EIN.: 475267544 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13D